One of the new and very promising drugswith coronary heart disease (CHD) is the drug "Predizin". Reviews of specialists, as well as clinical observations suggest that the use of this tool significantly reduces the number of episodes of angina (more than three times), reduces the need for the use of nitrates. In addition, the drug, being a metabolic modulator (capable of changing metabolic processes in cells) of myocardial cells, ensuring their protection from ischemia, increases endurance exercise, improves contractility in the left ventricle, lowers blood pressure drops.
The drug "Predizin" instruction characterizes as the only cytoprotector (myocardial), approved for use as an antianginal agent.
The drug is able to improve metabolism (exchangeprocesses) in the myocardium and neurosensory organs in ischemia. The active ingredient - trimetazidine - has antihypoxic properties. The active ingredient optimizes the function and metabolism of cardiomyocytes and neurons in the brain by direct exposure to them. The cytoprotective effect is associated with an increase in energy potential, rationalization in oxygen consumption.
Medicine "Predizin". Instructions for use: indications
The drug is recommended for coronary heart disease to prevent attacks of angina (in complex treatment), cochleo-vestibular disorders of ischemic nature.
Describing the drug "Predizin" instruction onapplication indicates its ability to reduce intracellular ascidosis (shift of acid-base balance in the direction of high acidity) and an increase in phosphate levels. The drug prevents the damaging effects of free radicals and preserves the integrity of the cell membranes. With angina predisin drug reduces the frequency of attacks. When it is used, there is no need to use nitrates (nitroglycerin, in particular), tinnitus and vertigo are reduced. In the presence of vascular pathologies of the eye, functional activity in the retina improves.
Drug "Predizin". Instructions for use
The drug is prescribed by 35 mg (one tablet) orally, twice a day. It is recommended to take with food in the evening and in the morning. The duration of treatment is determined by the attending physician.
The drug "Predizin". Instructions for use: contraindications
Do not prescribe a drug for renal,liver failure, impaired kidney function, liver of a pronounced nature, under the age of eighteen years (due to lack of information about safety and efficacy), during pregnancy, intolerance, lactation.
After taking the drug "Predizin" oftenmarked abdominal pain, vomiting, dyspepsia, nausea, diarrhea, headache, dizziness, urticaria, skin rash, asthenia. Rarely there are flushing, tremor, rigidity (difficulties in perceiving the surrounding situation, reversible after stopping the medication), orthostatic hypotension.
The medicine "Predizin" is not intended foreliminate angina attacks. The drug is not used in the initial therapeutic course of myocardial infarction or unstable angina. With the development of an attack, it is necessary to revise the treatment.
The drug "Predizin" does not affect the ability to drive vehicles or engage in activities associated with increased concentration of attention.
Cases of overdose in clinical practice are not fully described. If any undesirable reactions occur, please consult a specialist.
